1. Home
  2. NRSN vs LEE Comparison

NRSN vs LEE Comparison

Compare NRSN & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • LEE
  • Stock Information
  • Founded
  • NRSN 2017
  • LEE 1890
  • Country
  • NRSN Israel
  • LEE United States
  • Employees
  • NRSN N/A
  • LEE N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • NRSN Health Care
  • LEE Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • LEE Nasdaq
  • Market Cap
  • NRSN 29.8M
  • LEE 33.8M
  • IPO Year
  • NRSN 2021
  • LEE N/A
  • Fundamental
  • Price
  • NRSN $0.98
  • LEE $4.55
  • Analyst Decision
  • NRSN Buy
  • LEE
  • Analyst Count
  • NRSN 2
  • LEE 0
  • Target Price
  • NRSN $14.00
  • LEE N/A
  • AVG Volume (30 Days)
  • NRSN 202.0K
  • LEE 67.3K
  • Earning Date
  • NRSN 12-17-2025
  • LEE 12-11-2025
  • Dividend Yield
  • NRSN N/A
  • LEE N/A
  • EPS Growth
  • NRSN N/A
  • LEE N/A
  • EPS
  • NRSN N/A
  • LEE N/A
  • Revenue
  • NRSN N/A
  • LEE $581,809,000.00
  • Revenue This Year
  • NRSN N/A
  • LEE N/A
  • Revenue Next Year
  • NRSN N/A
  • LEE N/A
  • P/E Ratio
  • NRSN N/A
  • LEE N/A
  • Revenue Growth
  • NRSN N/A
  • LEE N/A
  • 52 Week Low
  • NRSN $0.80
  • LEE $3.79
  • 52 Week High
  • NRSN $2.60
  • LEE $17.71
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 37.32
  • LEE 48.00
  • Support Level
  • NRSN $0.89
  • LEE $3.92
  • Resistance Level
  • NRSN $0.97
  • LEE $5.70
  • Average True Range (ATR)
  • NRSN 0.07
  • LEE 0.43
  • MACD
  • NRSN -0.01
  • LEE 0.07
  • Stochastic Oscillator
  • NRSN 26.22
  • LEE 25.84

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: